Novo Medix Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.60 M
as on 08-11-2024
- Paid Up Capital ₹ 0.60 M
as on 08-11-2024
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -20.68%
(FY 2023)
- Profit -51.80%
(FY 2023)
- Ebitda 15732.95%
(FY 2023)
- Net Worth 83.86%
(FY 2023)
- Total Assets 33.33%
(FY 2023)
About Novo Medix Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.60 M and a paid-up capital of Rs 0.60 M, as per Ministry of Corporate Affairs (MCA) records.
Aurobinda Banerjee, Abhijit Basu, Jyotirmoy Karmakar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85100WB2020PTC235666
- Company No.
235666
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jan 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Novo Medix Pharmaceutical?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhijit Basu  | Managing Director | 03-Jan-2020 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aurobinda Banerjee | Whole-Time Director | 03-Jan-2020 | Current |
| Jyotirmoy Karmakar | Whole-Time Director | 03-Jan-2020 | Current |
| Sabir Hossain | Additional Director | 27-Dec-2022 | Current |
| Khondaker Islam | Additional Director | 02-Aug-2021 | Current |
Financial Performance of Novo Medix Pharmaceutical.
Novo Medix Pharmaceutical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 20.68% decrease. The company also saw a substantial fall in profitability, with a 51.8% decrease in profit. The company's net worth Soared by an impressive increase of 83.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novo Medix Pharmaceutical?
Unlock access to Novo Medix Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Novorel Medical Devices Private LimitedActive 6 years 6 monthsAurobinda Banerjee is a mutual person
- Feminova Pharmaceuticals Private LimitedActive 3 years 8 months
Aurobinda Banerjee, Abhijit Basu and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Novo Medix Pharmaceutical?
Novo Medix Pharmaceutical has a workforce of 20 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novo Medix Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novo Medix Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
